| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000029141 |
| Receipt No. | R000033319 |
| Official scientific title of the study | Clinical Evaluation of the Effects of Dietary Sulforaphane on Sleep in Healthy Volunteers |
| Date of disclosure of the study information | 2017/09/14 |
| Last modified on | 2018/09/28 (Ver. 5) |
| Basic information | ||
| Official scientific title of the study | Clinical Evaluation of the Effects of Dietary Sulforaphane on
Sleep in Healthy Volunteers |
|
| Title of the study (Brief title) | Effects of Dietary Sulforaphane on Sleep | |
| Region |
|
|
| Condition | |||
| Condition | Healthy adults | ||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | The aim of this study is to evaluate the efficacy of intervention with dietary supplement "sulforaphane" on sleep quality of healthy subjects. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Sleep questionnaire(Oguri-Shirakawa-Azumi sleep questionnaire, The St. Mary's Hospital sleep questionnaire, VAS) before
and 1, 2, 4 weeks after the intervention with "sulforaphane" or placebo. |
| Key secondary outcomes | Sleep monitoring by wearable devices,
Autonomic nervous function tests, Salivary markers(Humoral factor), Physical parameters |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Double blind -all involved are blinded |
| Control | Placebo |
| Stratification | YES |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Prevention | |
| Type of intervention |
|
|
| Interventions/Control_1 | Dietary supplement "Sulforaphane"(3 capsules/day
for 4 weeks) |
|
| Interventions/Control_2 | Placebo supplement (3 capsules/day for 4 weeks) | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1) Healthy Japanese adults who do not receive
any treatments 2) Subjects who are not satisfied with their sleep quality 3) Subjects who habitually consume less amount of alcohol than avg 20 g/day 4) Subjects who can give the latest date of medical checkup |
|||
| Key exclusion criteria | 1) Subjects with heart disease, kidney disease, diabetes and other serious disease
2) Subjects who had serious disease and judge not to be suitable for this study 3) Subjects with risk of allergy regarding to this study 4) Subjects who have irregular life style 5) Subjects who cannot stop the use of medicines, herbal medicines and health foods which may affect sleep quality 6) Subjects who cannot take interventional foods following instructions and write life diary 7) Subjects who are in other clinical trials, or participated in other clinical trials within 2 months 8) Subjects who are judged unsuitable for this study by principal investigator and doctors |
|||
| Target sample size | 15 | |||
| Research contact person | |
| Name of lead principal investigator | Yasuhiro Nishizaki |
| Organization | Tokai University School of Medicine |
| Division name | Dept. of Clinical Health Science |
| Address | 143 Shimokasuya, Isehara, Kanagawa, 259-1193, Japan |
| TEL | 0463-93-1121 |
| y-nishizaki@tokai.ac.jp | |
| Public contact | |
| Name of contact person | Noriaki Kishimoto |
| Organization | Tokai University School of Medicine |
| Division name | Dept. of Clinical Health Science |
| Address | 143 Shimokasuya, Isehara, Kanagawa, 259-1193, Japan |
| TEL | 0463-93-1121 |
| Homepage URL | |
| kissy@tokai-u.jp | |
| Sponsor | |
| Institute | Tokai University School of Medicine |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Kagome. CO., LTD. |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 東海大学医学部付属病院(Tokai University Hospital)
カゴメ株式会社(Kagome. CO., LTD.) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000033319 |